je.st
news
Tag: fda
Zoetis gains FDA approval on medicated feed cross-clearances
2015-09-03 06:00:00| National Hog Farmer
The U.S. Food and Drug Administration has approved new combination uses of Zoetis’ feed additives Actogain 45 (ractopamine hydrochloride) and Engain (ractopamine hydrochloride). Pork producers, veterinarians and nutritionists may now use Engain together with Tylovet 100. These combinations have previously been approved with Tylan (tylosin phosphate). Beef producers, together with their veterinarians and nutritionists, will now be able to use Actogain 45 in combination with Rumensin (monensin USP) plus Tylovet 100 (tylosin phosphate). read more
Bay Area startup's wireless digital stethoscopes and smartphone app cleared by FDA
2015-09-02 20:23:45| Wireless - Topix.net
Doctors can now buy a Bay Area startup's next generation stethoscope to wirelessly stream heart sounds to their smartphones and directly into their patients' electronic records. Device maker Eko emerged last year from a startup program at UC Berkeley, the Stanford-affiliated StartX accelerator and Founder.org, a program created by Splunk founder Michael Baum .
Tags: area
digital
wireless
bay
FDA Approves Pediatric Indication for EMEND (aprepitant) Capsules in Combination with Other Antiemetic Agents
2015-09-02 14:00:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for EMEND (aprepitant) capsules, a substance P/neurokinin 1 (NK1) receptor antagonist. Language: English Contact: MerckMedia:Doris Li, 908-740-1903An Phan, 908-255-6325orInvestors:Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: combination
agents
indication
pediatric
RetroSense Therapeutics' Lead Gene Therapy Candidate Gets FDA Clearance To Proceed To First-In-Human Clinical Trials
2015-09-02 07:40:59| drugdiscoveryonline News Articles
RetroSense Therapeutics LLC, a privately-held biopharmaceutical company, recently announced the Company’s Investigational New Drug (IND) application for RST-001 received clearance from the United States Food and Drug Administration (FDA)
Tags: lead
clinical
therapy
candidate
FDA approves Amgen's cholesterol-lowering drug Repatha
2015-08-28 02:31:47| Biotech - Topix.net
WASHINGTON: The U.S. Food and Drug Administration on Thursday approved Amgen Inc's Repatha drug for patients with hereditary forms of high cholesterol and those with cardiovascular disease. Last month the FDA approved a similar drug from Regeneron Pharmaceuticals Inc and Sanofi SA.
Tags: drug
fda
approves
fda approves
Sites : [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] next »